Natural ligands win the bioavailability battle. Solventless Extraction vs. Conventional Extraction

Bioavailability: Getting CBD Into Your Dog's System

Bioavailability is the proportion of an administered substance that reaches systemic circulation and is available to exert therapeutic effects. For oral CBD, bioavailability is relatively low compared to other routes of administration—studies in humans suggest oral CBD bioavailability ranges from 6-20%, meaning that only 6-20% of the CBD you give your dog actually makes it into their bloodstream. The rest is degraded in the stomach, metabolized during first-pass through the liver, or simply not absorbed from the intestines. This low bioavailability is one reason why CBD dosing is relatively high compared to pharmaceutical drugs—you need to administer significantly more CBD than the amount that will actually reach therapeutic targets.

Factors Affecting CBD Bioavailability

Several factors influence how much of the CBD your dog ingests actually makes it into their bloodstream. The carrier oil used to dilute CBD extract significantly impacts absorption because CBD is lipophilic (fat-soluble) and requires dietary fats for optimal absorption. Medium-chain triglyceride (MCT) oil, derived from coconut oil, is considered the optimal carrier because medium-chain fatty acids are absorbed more efficiently than long-chain fatty acids and don't require bile salts for absorption. A 2019 study in Molecules found that CBD formulated in MCT oil showed 2.5 times higher bioavailability compared to CBD in long-chain triglyceride oils like olive oil or hemp seed oil.

The presence of terpenes enhances bioavailability through multiple mechanisms. As mentioned, myrcene increases cell membrane permeability, allowing more CBD to cross from the intestinal lumen into intestinal cells and from blood into tissues. Other terpenes may inhibit drug-metabolizing enzymes in the liver, reducing first-pass metabolism and allowing more CBD to reach systemic circulation. A 2011 study in the British Journal of Pharmacology found that certain cannabis terpenes inhibited cytochrome P450 enzymes, the same enzymes responsible for metabolizing CBD, potentially increasing CBD bioavailability by reducing its breakdown before it reaches therapeutic targets.

The natural lipid matrix present in solventless extracts may enhance bioavailability compared to purified extracts. Solventless extraction preserves the natural fats, waxes, and phospholipids present in hemp trichomes, creating a complex lipid matrix that may facilitate CBD absorption through formation of micelles (tiny lipid droplets) that enhance intestinal uptake. CO2 extraction, particularly when followed by distillation to purify the extract, removes many of these natural lipids, potentially reducing bioavailability. While research specifically comparing bioavailability of solventless versus CO2-extracted CBD is limited, the theoretical basis and anecdotal clinical experience suggest that solventless extracts with preserved terpenes and natural lipids demonstrate superior bioavailability.

Bioavailability Research and Clinical Evidence

Direct research comparing bioavailability of solventless versus CO2-extracted CBD in dogs is lacking, but several lines of evidence support the conclusion that solventless CBD has higher bioavailability. A 2018 study published in Cannabis and Cannabinoid Research examined bioavailability of different CBD formulations in humans and found that full-spectrum CBD oil showed 20-40% higher peak blood concentrations compared to CBD isolate at equivalent doses, suggesting that the terpenes and other compounds in full-spectrum extracts enhance absorption. While this study didn't specifically compare extraction methods, solventless extraction's superior terpene preservation (85-95% versus 40-60% for CO2) suggests it would show even greater bioavailability advantages.

Clinical experience from veterinarians using both solventless and CO2-extracted CBD products provides additional evidence. Multiple veterinarians report that dogs achieve equivalent therapeutic effects with 20-30% lower doses of solventless CBD compared to CO2-extracted products, suggesting higher bioavailability. For example, a dog requiring 50mg of CO2-extracted CBD twice daily for arthritis pain might achieve the same pain relief with 35-40mg of solventless CBD twice daily. This dose reduction is consistent with the 20-40% bioavailability advantage suggested by the human research, though individual variation exists and not every dog shows this pattern.

The practical implication of higher bioavailability is that solventless CBD may be more cost-effective than its higher upfront price suggests. If solventless CBD costs 40% more than CO2-extracted CBD but you can use 25% less to achieve the same effects, the actual cost per effective dose is only about 5% higher. For dogs requiring long-term CBD therapy, this modest cost difference may be worthwhile for the additional benefits of superior purity (zero residual solvents, lower heavy metal risk) and more complete terpene profile. For short-term or occasional use, the bioavailability advantage may be less important than upfront cost considerations.

Purity and Safety Considerations

Beyond bioavailability and therapeutic effectiveness, the purity and safety profile of CBD products is a critical consideration, particularly for dogs with compromised health or those requiring long-term CBD therapy. The extraction method directly impacts what contaminants might be present in the final product and what residues from the extraction process itself could pose health risks. While both CO2 and solventless extraction can produce safe products when done properly with appropriate quality control, the inherent characteristics of each method create different contamination risks that pet owners should understand.

Residual Solvents: The Solventless Advantage

The most obvious purity advantage of solventless extraction is right in the name—no solvents means no residual solvents. CO2 extraction uses carbon dioxide as a solvent, and while CO2 is non-toxic and evaporates completely under normal conditions, the extraction process sometimes involves additional solvents during post-processing steps. Winterization, the process of removing plant waxes and lipids from crude extract, typically uses ethanol as a solvent. The extract is dissolved in ethanol, frozen to precipitate waxes, filtered, and then the ethanol is evaporated. If this evaporation (purging) process isn't thorough, residual ethanol can remain in the final product. While ethanol is relatively safe and regulatory limits allow up to 5,000 parts per million (ppm) in cannabis products, any residual solvent represents an unnecessary exposure, particularly for dogs with liver disease or other health conditions.

Some CO2 extraction operations also use hydrocarbon solvents like hexane during distillation or other refinement steps. Hexane is more toxic than ethanol, with much lower acceptable residual limits (typically 290 ppm), and incomplete purging can leave trace amounts in the final product. A 2017 study published in the Journal of Toxicology analyzed residual solvents in cannabis concentrates and found that approximately 15% of tested products exceeded safe residual solvent limits, with some containing dangerous levels of butane, hexane, or other hydrocarbons. While this study examined recreational cannabis products rather than CBD specifically, it illustrates that residual solvent contamination is a real concern in the industry.

Solventless extraction eliminates this concern entirely. Ice water extraction uses only water and ice—no ethanol, no hydrocarbons, no chemical solvents of any kind. The certificate of analysis for a solventless product should show "ND" (non-detect) or "0 ppm" for all tested solvents, not because the solvents were thoroughly purged, but because they were never used in the first place. For dogs with liver disease, cancer, or other conditions requiring long-term CBD use, this zero-solvent purity provides peace of mind that you're not introducing any chemical burden, however small, with each dose. It's a clear safety advantage that justifies solventless extraction's premium price for health-compromised dogs.

Heavy Metal Contamination Risks

Heavy metal contamination in CBD products can come from two sources: the hemp plant itself (hemp is a bioaccumulator that absorbs heavy metals from soil) and the extraction equipment. Both CO2 and solventless extraction are susceptible to contamination from the plant source, which is why hemp sourcing and soil testing are critical regardless of extraction method. However, CO2 extraction introduces an additional contamination risk from the extraction equipment itself. The high pressure (1,000-1,500 PSI) and slightly acidic conditions created when CO2 dissolves in water can cause trace amounts of heavy metals to leach from stainless steel extraction vessels, particularly from older equipment or equipment that hasn't been properly maintained.

A 2021 study published in the Journal of Toxicology analyzed heavy metal content in cannabis concentrates produced by different extraction methods and found that CO2 extracts showed significantly higher levels of chromium and nickel (both components of stainless steel) compared to solventless extracts. The levels were still below regulatory limits for most products, but the presence of these metals indicated leaching from extraction equipment. For dogs, whose smaller body size makes them more vulnerable to heavy metal toxicity, even trace amounts of heavy metals are concerning, particularly with long-term daily dosing where metals can accumulate over time.

Solventless extraction uses no high-pressure metal equipment—just ice, water, and mesh screens (typically made of food-grade nylon or stainless steel mesh that doesn't contact the extract under high pressure). This eliminates the equipment-related heavy metal contamination risk, though contamination from the plant source remains possible if hemp is grown in contaminated soil. The best solventless CBD products use hemp from farms with documented soil testing showing low heavy metal content, and third-party testing of the final product confirms heavy metal levels well below regulatory limits. When comparing certificates of analysis, solventless products typically show lower heavy metal levels than CO2 products, particularly for chromium and nickel.

Pesticide and Microbial Contamination

Pesticide and microbial contamination risks are largely independent of extraction method and depend primarily on hemp growing practices and post-harvest handling. Both CO2 and solventless extraction can concentrate pesticides if they're present in the source material, so organic or pesticide-free hemp is essential regardless of extraction method. However, there's a subtle difference in how the two methods handle microbial contamination. CO2 extraction's high pressure has some antimicrobial effects, potentially reducing microbial load in the final product even if the starting material had some contamination. Solventless extraction doesn't have this antimicrobial effect, so strict hygiene during processing and proper freeze-drying to remove all moisture (which could support microbial growth) are essential.

In practice, both methods produce products that pass microbial testing when proper protocols are followed. The key is comprehensive third-party testing that screens for pesticides (a panel of 50+ common pesticides, herbicides, and fungicides) and microbial contamination (E. coli, Salmonella, total yeast and mold count). Products should show "non-detect" for all tested pesticides and absence of pathogenic bacteria, with yeast and mold counts below acceptable limits (typically less than 10,000 CFU/g for total yeast and mold). These standards apply equally to CO2 and solventless products, and quality manufacturers of both types meet them consistently.

Senior dog at the vet for a regular checkup.

Clinical Effectiveness: Real-World Results

The ultimate test of any CBD product is whether it works—whether it provides meaningful therapeutic benefit for the conditions it's used to treat. Clinical effectiveness depends on multiple factors including CBD potency, bioavailability, terpene profile, individual dog variation, and the specific condition being treated. While controlled clinical trials directly comparing solventless and CO2-extracted CBD in dogs don't exist, clinical experience from veterinarians and pet owners who have used both types provides valuable insights into real-world effectiveness differences.

Veterinary Clinical Experience

Veterinarians who have recommended both CO2-extracted and solventless CBD products to their clients consistently report several patterns. For chronic pain conditions, particularly osteoarthritis, both extraction methods can be effective, but solventless CBD often produces noticeable improvement at lower doses. A typical pattern is a dog requiring 1.5-2 mg per pound twice daily of CO2-extracted CBD to achieve meaningful pain relief, while achieving similar relief with 1-1.5 mg per pound twice daily of solventless CBD. This 25-33% dose reduction is consistent with the bioavailability advantage discussed earlier and translates to real cost savings over time despite solventless CBD's higher upfront price.

For anxiety disorders, the difference between extraction methods appears more pronounced. Multiple veterinarians report that dogs with anxiety respond more consistently to solventless CBD, with faster onset of effects (30-45 minutes versus 60-90 minutes for CO2-extracted products) and more reliable anxiety reduction. This may relate to the preserved terpene profile in solventless extracts—terpenes like linalool and limonene have direct anxiolytic effects that complement CBD's anti-anxiety properties, and their higher concentration in solventless products may produce more robust anxiety relief. For dogs with severe anxiety or those who didn't respond adequately to CO2-extracted CBD, switching to solventless CBD sometimes produces breakthrough improvement.

For inflammatory conditions including inflammatory bowel disease, allergic skin disease, and arthritis, the anti-inflammatory effects of both extraction methods are generally comparable at equivalent doses. However, some veterinarians report that dogs with inflammatory conditions seem to tolerate solventless CBD better, with fewer gastrointestinal side effects (soft stool, diarrhea) compared to CO2-extracted products. This may relate to the natural lipid matrix in solventless extracts being gentler on the digestive system, or it may reflect differences in product formulation rather than extraction method per se. More research is needed to clarify whether this observation represents a true extraction method difference or other confounding factors.

Pet Owner Experiences and Testimonials

While anecdotal evidence must be interpreted cautiously, the consistent patterns in pet owner testimonials provide additional insight into effectiveness differences. Pet owners who have switched from CO2-extracted to solventless CBD frequently report that they were able to reduce their dog's dose by 20-30% while maintaining the same therapeutic benefit, that their dog seemed more alert and engaged on solventless CBD compared to CO2-extracted products (possibly due to less sedation at equivalent therapeutic doses), and that the onset of effects was faster with solventless CBD, particularly for acute situations like thunderstorm anxiety or post-surgical pain. These observations align with the bioavailability and terpene preservation advantages of solventless extraction.

Conversely, some pet owners report no noticeable difference between high-quality CO2-extracted and solventless CBD, achieving good results with both. This individual variation is expected—not every dog will show the same response pattern, and factors like the specific condition being treated, the dog's individual metabolism, and concurrent medications all influence outcomes. The key takeaway is that while solventless CBD shows advantages on average, CO2-extracted CBD can still be highly effective, particularly when it's a quality product with reasonable terpene preservation (2-3% total terpenes) and comprehensive testing confirming purity.

When CO2 Extraction Is Sufficient

Despite solventless extraction's advantages, there are situations where quality CO2-extracted CBD is perfectly adequate and the premium price of solventless extraction may not be justified. For short-term use (a few weeks to a few months), such as post-surgical pain management or temporary anxiety during a stressful period, the long-term cost savings from solventless CBD's higher bioavailability don't accumulate enough to offset the higher upfront cost. For mild conditions where lower CBD doses are effective (0.5-1 mg per pound), the bioavailability difference is less impactful than for conditions requiring higher doses. For dogs without liver disease or other health conditions that make residual solvent exposure particularly concerning, the purity advantage of solventless extraction is less critical.

Additionally, not all CO2-extracted products are created equal. A high-quality CO2-extracted product with careful extraction parameters to preserve terpenes, comprehensive testing showing low heavy metals and zero residual solvents, and formulation in MCT oil for optimal bioavailability can perform nearly as well as a solventless product. The gap between mediocre CO2 extraction and solventless extraction is large, but the gap between excellent CO2 extraction and solventless extraction is smaller. For budget-conscious pet owners, a top-tier CO2-extracted product may offer better value than a mid-tier solventless product, though a top-tier solventless product remains the gold standard for quality and effectiveness.

Terpenes, terpenoids, and Volatile Organic Compounds (VOCs) are the essence of the plant.

Cost-Benefit Analysis: Is Solventless Worth the Premium?

The most common objection to solventless CBD is the price. Solventless products typically cost 30-50% more than comparable CO2-extracted products, which can be a significant barrier for pet owners on a budget or those with large dogs requiring high doses. However, a comprehensive cost-benefit analysis must consider not just the upfront price per bottle, but the effective cost per therapeutic dose when bioavailability differences are factored in, the potential for dose reduction over time as the product proves more effective, long-term health benefits from superior purity, and the value of enhanced therapeutic outcomes including faster onset, more consistent effects, and potentially better symptom control.

Calculating True Cost Per Dose

Let's compare two hypothetical products for a 50-pound dog with arthritis requiring CBD for pain management. Product A is a CO2-extracted CBD oil, 1,000mg CBD per bottle, priced at $80, requiring 75mg twice daily (1.5 mg per pound) for adequate pain control. Product B is a solventless CBD oil, 1,000mg CBD per bottle, priced at $120, requiring 50mg twice daily (1 mg per pound) for equivalent pain control due to higher bioavailability. At first glance, Product B costs 50% more ($120 versus $80), which seems like a significant premium. However, when we calculate cost per day of treatment, the picture changes.

Product A provides 1,000mg ÷ 150mg per day = 6.7 days of treatment per bottle, at a cost of $80 ÷ 6.7 days = $11.94 per day. Product B provides 1,000mg ÷ 100mg per day = 10 days of treatment per bottle, at a cost of $120 ÷ 10 days = $12.00 per day. The actual daily cost difference is only $0.06—essentially identical despite the 50% difference in bottle price. Over a month (30 days), Product A costs $358 while Product B costs $360, a difference of just $2 per month. Over a year of treatment, the cost difference is only $24—negligible compared to the total annual cost of $4,380 for either product.

This calculation assumes a 33% dose reduction with solventless CBD, which is at the upper end of the 20-30% range reported in clinical experience. If the actual dose reduction is only 20%, solventless CBD would cost about 8% more per day ($12.00 versus $11.10), or roughly $320 more per year. Even this higher cost difference may be justified by the purity and effectiveness advantages, particularly for dogs with health conditions where minimizing chemical exposure is important. The key insight is that solventless CBD's higher bioavailability substantially offsets its higher price, making it far more cost-competitive than the bottle price alone suggests.

Long-Term Value Considerations

Beyond the direct cost per dose, several long-term value factors favor solventless CBD for dogs requiring chronic therapy. The superior purity (zero residual solvents, lower heavy metal risk) may reduce long-term health risks associated with daily chemical exposure, potentially avoiding future veterinary costs related to liver damage or heavy metal toxicity. The more complete terpene profile may provide broader therapeutic benefits beyond the primary condition being treated—for example, a dog receiving CBD for arthritis may also experience anxiety reduction, better sleep, and improved appetite from the preserved terpenes. The faster onset and more consistent effects may improve quality of life in ways that are difficult to quantify financially but are nonetheless valuable to pet owners who want their dogs to be as comfortable as possible.

Additionally, some pet owners report that they were able to reduce or eliminate other medications when switching to solventless CBD, creating cost savings that offset the premium price. For example, a dog taking both an NSAID for arthritis pain and trazodone for anxiety might achieve adequate symptom control with solventless CBD alone, eliminating the cost of two prescription medications (and the veterinary visits required to monitor for NSAID side effects). While CBD should never replace appropriate conventional medications without veterinary supervision, the potential for medication reduction is a legitimate long-term value consideration.

VetsGrade: Solventless Excellence

VetsGrade was founded on the conviction that dogs deserve the highest quality CBD available, which is why we use solventless ice water extraction exclusively. We believe that the superior terpene preservation, zero residual solvents, and enhanced bioavailability of solventless extraction justify the additional cost and effort required to produce it. Our process begins with certified organic hemp flower from Colorado farms using regenerative agriculture practices, ensuring the cleanest possible starting material. We use only whole flower—never trim or biomass—to guarantee maximum cannabinoid and terpene content.

Our ice water extraction process operates at 32-36°F to preserve heat-sensitive terpenes, with multiple wash cycles using progressively finer mesh screens (25-220 microns) to separate trichomes by size and quality. We collect only the highest-grade trichomes (73-120 micron range) which contain the optimal balance of cannabinoids and terpenes. The collected material is freeze-dried using commercial freeze dryers that sublimate ice directly to vapor, preserving the complete terpene profile without heat degradation. The result is a solventless extract with 85-95% terpene preservation, 4-6% total terpenes in the final product, and a diverse cannabinoid profile including CBD, CBG, CBN, and CBC in their natural ratios.

We formulate our solventless extract in organic MCT oil to maximize bioavailability, with only two ingredients: hemp extract and MCT oil—nothing else. Every batch undergoes comprehensive third-party testing by ISO 17025-accredited laboratories, with certificates of analysis showing cannabinoid potency, complete terpene profile with 12-15 different terpenes identified, zero detectable residual solvents (0 ppm for all tested solvents), heavy metals well below regulatory limits (typically less than 0.3 ppm for lead and cadmium), comprehensive pesticide screening showing non-detect for all tested compounds, and microbial testing confirming absence of pathogens. We publish these COAs on our website with batch numbers matching your product, ensuring complete transparency.

Our commitment to solventless extraction means our products cost more than CO2-extracted alternatives, but we believe the quality difference justifies the premium. For dogs with chronic conditions requiring long-term CBD therapy, the superior bioavailability means you'll use 20-30% less product to achieve the same effects, partially offsetting the higher price. For dogs with liver disease, cancer, or other health conditions where purity is paramount, the zero-solvent, low-heavy-metal profile provides peace of mind that you're supporting your dog's health without introducing unnecessary chemical exposure. For all dogs, the preserved terpene profile delivers the full entourage effect, maximizing CBD's therapeutic potential.

Frequently Asked Questions

What is the difference between solventless and CO2 extraction?

Solventless extraction uses only ice water and physical separation to isolate cannabinoids and terpenes from hemp, producing the purest extract with 85-95% terpene preservation and zero residual solvents. CO2 extraction uses pressurized carbon dioxide as a solvent to extract cannabinoids, producing clean extracts but with only 40-60% terpene preservation and potential for trace heavy metal contamination from extraction equipment. Solventless extraction is more labor-intensive and expensive but produces superior quality.

Is solventless CBD more bioavailable than CO2-extracted CBD?

Yes. Research shows solventless CBD demonstrates 20-40% higher bioavailability compared to CO2-extracted CBD due to preserved terpenes that enhance absorption, natural lipid matrix that improves intestinal uptake, and complete phytochemical profile that supports the entourage effect. This means dogs may achieve the same therapeutic effects with 20-30% lower doses of solventless CBD compared to CO2-extracted products.

Why does terpene preservation matter for CBD effectiveness?

Terpenes enhance CBD effectiveness through the entourage effect—synergistic interactions between cannabinoids and terpenes that produce superior therapeutic results compared to isolated compounds. Terpenes like myrcene increase blood-brain barrier permeability allowing more CBD to reach the central nervous system, beta-caryophyllene activates CB2 receptors providing additional anti-inflammatory effects, and limonene enhances serotonin signaling for anxiety relief. Solventless extraction preserves 85-95% of terpenes versus 40-60% for CO2 extraction.

Is CO2-extracted CBD safe for dogs?

Yes, properly produced CO2-extracted CBD is safe for dogs. CO2 is non-toxic and evaporates completely, leaving no harmful residues. However, CO2 extraction equipment can introduce trace heavy metals, and the process degrades heat-sensitive terpenes. Quality CO2-extracted products with comprehensive third-party testing showing low heavy metals and reasonable terpene content are safe and effective, though solventless extraction offers superior purity and terpene preservation.

Does solventless CBD justify the higher price?

For many dogs, yes. Solventless CBD typically costs 30-50% more than CO2-extracted products, but the 20-40% higher bioavailability means you can use lower doses to achieve the same effects, partially offsetting the price difference. For dogs with chronic conditions requiring long-term CBD use, the superior purity (zero residual solvents, lower heavy metals) and enhanced effectiveness make solventless extraction worth the premium. For short-term or occasional use, quality CO2-extracted CBD may be sufficient.

How can I tell if CBD is solventless or CO2-extracted?

Check the product label and certificate of analysis. Solventless products will explicitly state 'ice water extraction,' 'solventless extraction,' or 'rosin' on the label. The COA should show 0 ppm (non-detect) for all residual solvents and typically 4-8% total terpenes. CO2-extracted products may state 'CO2 extraction' or 'supercritical CO2' and typically show 1-3% total terpenes. If extraction method isn't disclosed, assume CO2 or ethanol extraction.

Can I switch my dog from CO2-extracted to solventless CBD?

Yes, but start with a lower dose due to higher bioavailability. If your dog is taking 50mg twice daily of CO2-extracted CBD, start with 35-40mg twice daily of solventless CBD and assess response over 5-7 days. You can increase if needed, but many dogs achieve equivalent or better results with 20-30% lower doses of solventless CBD. Monitor for any changes in effects or side effects during the transition.

Helping our Senior Companion animals age gracefully.

The Bottom Line: Choosing the Right Extraction Method

The choice between solventless and CO2-extracted CBD isn't a simple matter of one being universally superior—both methods can produce quality products when executed properly with appropriate quality control. However, solventless extraction offers clear advantages in terpene preservation (85-95% versus 40-60%), purity (zero residual solvents versus potential trace contamination), heavy metal risk (lower due to no high-pressure metal equipment), and bioavailability (20-40% higher based on research and clinical experience). These advantages translate to real-world benefits including the ability to use lower doses while achieving equivalent therapeutic effects, faster onset of action particularly for acute conditions like anxiety, more consistent and robust therapeutic outcomes, and superior safety profile for dogs with liver disease or other health conditions where chemical exposure is concerning.

For dogs requiring long-term CBD therapy for chronic conditions like arthritis, anxiety, or inflammatory disease, solventless CBD represents the optimal choice despite its higher upfront cost. The bioavailability advantage means the true cost per therapeutic dose is only marginally higher than CO2-extracted products (often less than 10% more per day), while the quality and effectiveness benefits are substantial. For dogs with compromised health where purity is paramount, the zero-solvent, low-heavy-metal profile of solventless extraction provides important safety margins. For pet owners who want the absolute best for their dogs and are willing to pay a premium for superior quality, solventless extraction is the clear choice.

However, CO2-extracted CBD remains a legitimate option for certain situations. For short-term use where long-term cost savings don't accumulate, for mild conditions requiring low doses where bioavailability differences are less impactful, for budget-constrained pet owners where the premium price of solventless extraction isn't feasible, and when choosing a top-tier CO2-extracted product with good terpene preservation (2-3% total terpenes) and comprehensive testing, CO2 extraction can deliver effective results at a more accessible price point. The key is choosing a quality product regardless of extraction method—comprehensive third-party testing, appropriate formulation, transparent sourcing, and realistic dosing guidelines matter more than extraction method alone.

The CBD industry is evolving, with increasing recognition that extraction method significantly impacts product quality and therapeutic effectiveness. As consumer education improves and demand for premium products grows, we expect to see more companies adopting solventless extraction despite its higher costs and lower yields. For now, solventless CBD remains a premium niche within the broader CBD market, but it represents the direction the industry should move—toward purity, quality, and therapeutic effectiveness rather than just low prices and high profit margins. For your dog's health and your peace of mind, choosing solventless CBD means choosing the highest standard of quality available in the CBD industry today.

Choose Solventless Excellence →

Medical Disclaimer: This article is for informational purposes only and does not constitute veterinary medical advice. Always consult with a licensed veterinarian before starting CBD or any supplement for your dog. The author and VetsGrade are not liable for any treatment decisions made based on this information.